Binding and Kinetics for Experimental Biologists Lecture 4 Equilibrium Binding: Case Study Petr Kuzmič, Ph.D. BioKin, Ltd. WATERTOWN, MASSACHUSETTS, U.S.A.

Slides:



Advertisements
Similar presentations
General Structural Equation (LISREL) Models
Advertisements

Structural Equation Modeling
Binding and Kinetics for Experimental Biologists Lecture 3 Equilibrium binding: Theory Petr Kuzmič, Ph.D. BioKin, Ltd. WATERTOWN, MASSACHUSETTS, U.S.A.
Determination of Binding Affinities and Molecular Mechanisms Petr Kuzmič BioKin, Ltd. Part 1: Theory Training Day May 2, 2014 (London)
Petr Kuzmič, Ph.D. BioKin, Ltd. WATERTOWN, MASSACHUSETTS, U.S.A. Binding and Kinetics for Experimental Biologists Lecture 8 Optimal design of experiments.
Bioinformatics Phylogenetic analysis and sequence alignment The concept of evolutionary tree Types of phylogenetic trees Measurements of genetic distances.
Incomplete Block Designs. Randomized Block Design We want to compare t treatments Group the N = bt experimental units into b homogeneous blocks of size.
Least squares CS1114
Petr Kuzmič, Ph.D. BioKin, Ltd. WATERTOWN, MASSACHUSETTS, U.S.A. Binding and Kinetics for Experimental Biologists Lecture 1 Numerical Models for Biomolecular.
Petr Kuzmič, Ph.D. BioKin, Ltd. WATERTOWN, MASSACHUSETTS, U.S.A. Binding and Kinetics for Experimental Biologists Lecture 7 Dealing with uncertainty: Confidence.
WATERTOWN, MASSACHUSETTS, U.S.A.
Numerical Enzyme Kinetics using DynaFit software
Covalent Inhibition Kinetics Application to EGFR Kinase
x – independent variable (input)
Ant Colonies As Logistic Processes Optimizers
Review of Matrix Algebra
Chapter 11 Multiple Regression.
Lecture 17 Interaction Plots Simple Linear Regression (Chapter ) Homework 4 due Friday. JMP instructions for question are actually for.
Numerical Enzymology Generalized Treatment of Kinetics & Equilibria Petr Kuzmič, Ph.D. BioKin, Ltd. DYNAFIT SOFTWARE PACKAGE.
Binding and Kinetics for Experimental Biologists Lecture 2 Evolutionary Computing : Initial Estimate Problem Petr Kuzmič, Ph.D. BioKin, Ltd. WATERTOWN,
1 Doing Statistics for Business Doing Statistics for Business Data, Inference, and Decision Making Marilyn K. Pelosi Theresa M. Sandifer Chapter 11 Regression.
Physics 114: Lecture 15 Probability Tests & Linear Fitting Dale E. Gary NJIT Physics Department.
Chapter 13: Inference in Regression
Factorial Experiments
Outline:1/31/07 n n Turn in Research Symposium Seminar reports – to me n n Exam 1 – two weeks from Friday… n Today: Start Chapter 15: Kinetics Kinetics.
Biochemical / Biophysical Kinetics “Made Easy” Software DYNAFIT in drug discovery research Petr Kuzmič, Ph.D. BioKin, Ltd. 1.Theory: differential equation.
WATERTOWN, MASSACHUSETTS, U.S.A.
Numerical Enzymology Generalized Treatment of Kinetics & Equilibria Petr Kuzmič, Ph.D. BioKin, Ltd. 1.Overview of recent applications 2.Selected examples.
Kinetics II Lecture 15. Rates and Concentrations Knowing the rate constant (usually empirically determined), we can compute rate. Integrating rate of.
Chemical Kinetics CHAPTER 14 Chemistry: The Molecular Nature of Matter, 6 th edition By Jesperson, Brady, & Hyslop.
Advanced Methods in Dose-Response Screening of Enzyme Inhibitors 1. Fitting model: Four-parameter logistic (IC 50 ) vs. Morrison equation (K i *) 2. Robust.
Biochemical Kinetics Made Easier Petr Kuzmič, Ph.D. BioKin, Ltd. 1.Theory: differential equations - DYNAFIT software 2.Example I: Initial rate experiment.
© 2014 Carl Lund, all rights reserved A First Course on Kinetics and Reaction Engineering Class 5.
VI. Evaluate Model Fit Basic questions that modelers must address are: How well does the model fit the data? Do changes to a model, such as reparameterization,
Rates of Reactions Why study rates?
Properties of OLS How Reliable is OLS?. Learning Objectives 1.Review of the idea that the OLS estimator is a random variable 2.How do we judge the quality.
Psych 5500/6500 Other ANOVA’s Fall, Factorial Designs Factorial Designs have one dependent variable and more than one independent variable (i.e.
ChE 553 Lecture 15 Catalytic Kinetics Continued 1.
Lecture 5 Model Evaluation. Elements of Model evaluation l Goodness of fit l Prediction Error l Bias l Outliers and patterns in residuals.
Irreversible Inhibition Kinetics1 Automation and Simulation Petr Kuzmič, Ph.D. BioKin, Ltd. 1.Automate the determination of biochemical parameters 2.PK/PD.
Module networks Sushmita Roy BMI/CS 576 Nov 18 th & 20th, 2014.
Biol 304 Week 3 Equilibrium Binding Multiple Multiple Binding Sites.
Introduction to Kinetics Lecture 14. Reading in Chapter 5 Read sections 5.1 through (p.160 to p. 199) and section 5.7 (p ). You won’t be.
Bio/Chemical Kinetics Made Easy A Numerical Approach Petr Kuzmič, Ph.D. BioKin, Ltd. 1. Case study: Inhibition of LF protease from B. anthracis 2. Method:
Analysis Overheads1 Analyzing Heterogeneous Distributions: Multiple Regression Analysis Analog to the ANOVA is restricted to a single categorical between.
Biological Function Equilibrium Binding. Many processes in biochemistry and pharmacology involve the reversible binding of one molecule to another and.
CHAPTER 27: One-Way Analysis of Variance: Comparing Several Means
Chapter 8: Simple Linear Regression Yang Zhenlin.
Introduction to Kinetics Lecture 14. Reading in Chapter 5 Read sections 5.1 through (p.160 to p. 199) and section 5.7 (p ). We will probably.
Nonlinear differential equation model for quantification of transcriptional regulation applied to microarray data of Saccharomyces cerevisiae Vu, T. T.,
Reaction Equilibrium Do any reactions truly go to completion??
Enzyme Kinetics I 10/15/2009. Enzyme Kinetics Rates of Enzyme Reactions Thermodynamics says I know the difference between state 1 and state 2 and  G.
The Concept of Dynamic Equilibrium – The Equilibrium Constant (K)
Computational methods for inferring cellular networks II Stat 877 Apr 17 th, 2014 Sushmita Roy.
Designs for Experiments with More Than One Factor When the experimenter is interested in the effect of multiple factors on a response a factorial design.
The SweSAT Vocabulary (word): understanding of words and concepts. Data Sufficiency (ds): numerical reasoning ability. Reading Comprehension (read): Swedish.
Chapter 7. Classification and Prediction
Making R3C Autocatalytic
Some reactions occur is several sequential steps.
Chemical Kinetics *All of the v’s in this lecture were changed to r’s (if this is incorrect then the overlying textboxes can just be deleted)
Learning Sequence Motif Models Using Expectation Maximization (EM)
CHAPTER 29: Multiple Regression*
CHAPTER 26: Inference for Regression
1 Department of Engineering, 2 Department of Mathematics,
1 Department of Engineering, 2 Department of Mathematics,
1 Department of Engineering, 2 Department of Mathematics,
Where did we stop? The Bayes decision rule guarantees an optimal classification… … But it requires the knowledge of P(ci|x) (or p(x|ci) and P(ci)) We.
Regression Forecasting and Model Building
Model selection and fitting
Presentation transcript:

Binding and Kinetics for Experimental Biologists Lecture 4 Equilibrium Binding: Case Study Petr Kuzmič, Ph.D. BioKin, Ltd. WATERTOWN, MASSACHUSETTS, U.S.A. I N N O V A T I O N L E C T U R E S (I N N O l E C)

BKEB Lec 4: Equilibrium Binding2 Lecture outline Topics: - generalized numerical model for equilibrium binding data - PREVIEW: model discrimination analysis (Akaike Information Criterion, AIC) - representing equilibrium binding mechanisms in DynaFit: the “thermodynamic box”; exclusive vs. non-exclusive binding; interacting vs. non-interacting binding sites. Example: HIV-1 Rev responsible element (RRE) RNA sequence interacting with (a) a model peptide representing the Rev protein (b) Neomycin B as a potential Rev competitor Goal: determine molecular mechanism – “Rev” and “Neo” mutually exclusive?

BKEB Lec 4: Equilibrium Binding3 DynaFit: Analysis of complex equilibria UNIFORM USER INTERFACE: SYMBOLIC DESCRIPTION OF REACTION MECHANISM species names are arbitrary: P, D works as well as Prot, DNA equilibrium constant names are also arbitrary (K 1, K d1, K eq.1,...) any number of steps in mechanism any mechanism DynaFit automatically derives the underlying mathematical model

BKEB Lec 4: Equilibrium Binding4 DynaFit: Mathematical model for complex equilibria “UNDER THE HOOD”: A SYSTEM OF SIMULTANEOUS NONLINEAR ALGEBRAIC EQUATIONS Royer, C.A.; Smith, W.R.; and Beechem, J.M. (1990) “Analysis of binding in macromolecular complexes: A generalized numerical approach” Anal. Biochem., 191, Royer, C.A. and Beechem, J.M. (1992) “Numerical analysis of binding data: advantages, practical aspects, and implications” Methods Enzymol. 210, DynaFit uses a modification of algorithm “EQS” by W.R. Smith (1990) MATHEMATICAL DETAILS:

BKEB Lec 4: Equilibrium Binding5 Example: HIV-1 Rev response element (RRE) Rev REGULATES THE TRANSCRIPTION OF HIV-1 REGULATORY PROTEINS Cullen (1991) FASEB J. 5, nucleotide RRE RNA target sequence Rev trans-activator protein binds near here

BKEB Lec 4: Equilibrium Binding6 HIV-1 RRE / Rev / Neomycin B NEOMYCIN BINDS TO Rev RESPONSIBLE ELEMENT. COULD IT DISRUPT THE BINDING OF Rev? Suc-TRQARRNRRRRWRERQRAAAAK Rev model peptide: Lacourciere et al. (2000) Biochemistry 39, * fluorescent probe on U72

BKEB Lec 4: Equilibrium Binding7 HIV-1 RRE / Rev / Neomycin B – study plan 1.Experiment #1: Observe the binding of RRE to Rev 2.Experiment #2: Observe the binding of RRE to Neomycin 3.Experiment #3: Observe the binding of RRE to Rev + Neomycin 4.Compare the observations with two alternate mechanisms: a. Neomycin competes with Rev peptide... b. Neomycin does not compete with Rev peptide for binding to the fluorescently labeled RNA fragment 5.Conclude which of the two models is more likely to be true

BKEB Lec 4: Equilibrium Binding8 DynaFit script: Skeleton for fitting equilibrium data EVERY DYNAFIT SCRIPT HAS TO CONTAIN THESE SECTIONS [task] task = fit data = equilibria [mechanism] [constants] [concentrations] [responses] [data] variable... set... [output] directory... [set:...] [end] where to find the experimental data (not the data themselves) molar response coefficients (e.g., UV/Vis extinction coefficients) concentrations of reactants applicable to all data sets which component is varied in the binding experiment experimental data numerical estimates of equilibrium constants definitions of equilibrium constants

BKEB Lec 4: Equilibrium Binding9 Experiment #1: DynaFit script - mechanism NOTHING SPECIAL – JUST SIMPLE 1:1 BINDING [mechanism] R72 + Rev R72.Rev : K dissoc 1:1 Lacourciere et al. (2000) Biochemistry 39,

BKEB Lec 4: Equilibrium Binding10 Experiment #1: DynaFit script - constants LOOK FOR “HALF-MAXIMUM CONCENTRATION” TO ESTIMATE DISSOCIATION CONSTANTS [mechanism] R72 + Rev R72.Rev : K dissoc [constants] K =... half-maximum effect 0.02 µM 0.02 dissociation constants have the same dimension as concentrations units must be the same as those used in the experimental data! Lacourciere et al. (2000) Biochemistry 39,

BKEB Lec 4: Equilibrium Binding11 Experiment #1: DynaFit script - concentrations LIST ONLY CONSTANT (NOT VARIABLE) CONCENTRATIONS IDENTICAL IN ALL DATA SETS [mechanism] R72 + Rev R72.Rev : K dissoc [constants] K = 0.02 [concentrations] R72 = 0.03 Lacourciere et al. (2000) Biochemistry 39, [R72] = 30 nM units must be the same as those used in the experimental data!

BKEB Lec 4: Equilibrium Binding12 Experiment #1: DynaFit script - responses LIST ALL MOLECULAR SPECIES “VISIBLE” IN THE GIVEN EXPERIMENTS [mechanism] R72 + Rev R72.Rev : K dissoc [constants] K = 0.02 [concentrations] R72 = 0.03 [responses] R72 =... R72.Rev =... Lacourciere et al. (2000) Biochemistry 39, µM R72 signal = 1.0 “how much experimental signal is associated with one concentration unit of each visible species?” 1.0 / 0.03 = µM R72.Rev signal ~ / 0.03 =

BKEB Lec 4: Equilibrium Binding13 Experiment #1: DynaFit script - data [mechanism] R72 + Rev R72.Rev : K dissoc [constants] K = 0.02 [concentrations] R72 = 0.03 [responses] R72 = 33.3 R72.Rev = 66.6 [data] variable... set... Rev R72--Rev [set:R72--Rev] Figure 2B in Lacourciere et al. (2000) Rev,uMF370* a “comment” raw data courtesy of Jim Stivers Johns Hopkins University EXPERIMENTAL DATA CAN BE EMBEDDED IN THE SCRIPT OR RESIDE IN SEPARATE FILES

BKEB Lec 4: Equilibrium Binding14 Experiment #1: DynaFit – optimized parameters WHAT ARE THE “UNKNOWNS” IN THIS EXPERIMENT? [mechanism] R72 + Rev R72.Rev : K dissoc [constants] K = 0.02 [concentrations] R72 = 0.03 [responses] R72 = 33.3 R72.Rev = 66.6 [data] variable Rev set R72--Rev ? ? ? it’s not a given that the best-fit curve must go through the [0,1] data point!

BKEB Lec 4: Equilibrium Binding15 Experiment #1: DynaFit – initial estimate ALWAYS USE THIS FEATURE TO ASSESS THE QUALITY OF YOUR INITIAL ESTIMATE! K d = r R72 = r R72.Rev = 0.02 d 33.3 d 66.6 d

BKEB Lec 4: Equilibrium Binding16 Experiment #1: DynaFit – performing the fit K d = r R72 = r R72.Rev = d 33.4 d 67.8 d RUN THE SCRIPT ONLY WHEN THE INITIAL ESTIMATE LOOKS REASONABLY GOOD!

BKEB Lec 4: Equilibrium Binding17 A devil in the detail: Is our labeled [RNA] correct? DynaFit output: Special situation: the K d is lower than the (fixed) RNA concentration! [R72] = µM K d = µM “Where have I seen this before?”

BKEB Lec 4: Equilibrium Binding18 When the “fixed” concentration is higher than K d then it must be optimized, along with the K d !

BKEB Lec 4: Equilibrium Binding19 Experiment #1: Optimized parameters – Take 2 ADD ONE MORE “UNKNOWN” AND SEE WHAT HAPPENS... [mechanism] R72 + Rev R72.Rev : K dissoc [constants] K = 0.02 [concentrations] R72 = 0.03 [responses] R72 = 33.3 R72.Rev = 66.6 [data] variable Rev set R72--Rev ? ? ? * fluorescent probe on U72 ?

BKEB Lec 4: Equilibrium Binding20 Fixed or optimized [RNA]? Model selection results AKAIKE INFORMATION CRITERION IS INCONCLUSIVE K = (12.6 ± 2.1) nM [RNA] = 30 nM, fixed K = (5.5 ± 2.0) nM [RNA] = (47 ± 5) nM sum of squares did decrease by a factor of two however the number of adjustable parameters increased! this number must be larger than ~10 “Akaike weight” must be larger than ~0.95

BKEB Lec 4: Equilibrium Binding21 Fixed or optimized [RNA]? Confidence intervals THE “PLUS OR MINUS” STANDARD ERRORS ARE ALMOST ALWAYS WRONG (TOO SMALL) [task] task = fit data = equilibria [mechanism] R72 + Rev R72.Rev : K dissoc [constants] K = 0.02 ?? [concentrations] R72 = 0.03 ?? [responses] R72 = 33.3 ? R72.Rev = 66.6 ?... ?? “PROFILE-T” METHOD Watts, D. G. (1994) "Parameter estimation from nonlinear models“ Methods Enzymol. 240, Bates, D. M., and Watts, D. G. (1988) Nonlinear Regression Analysis and its Applications Wiley, New York, pp

BKEB Lec 4: Equilibrium Binding22 Confidence intervals: Results THE NOMINAL [RNA] CONCENTRATION IS PROBABLY INCORRECT K d, nM [R72], nM   57.2 parameterbest-fit value formal error, ± confidence interval (95%)... nominal: 30.0 DynaFit output: reasonable suspicion: actual RNA concentration might be higher by ~60% than the nominal value

BKEB Lec 4: Equilibrium Binding23 Experiment #2: RRE / Neomycin – raw data FIXED RRE-72AP CONCENTRATION: [R72] = 0.1 µM K d ~ 0.3 µM half-maximum effect only R72 (0.1 µM) molar response of R72 1.0/0.1 = 10 only R72.Neo (0.1 µM) molar response of R72.Neo 0.85/0.1 = 8.5 INITIAL ESTIMATES:

BKEB Lec 4: Equilibrium Binding24 Experiment #2: RRE / Neomycin – script USING INITIAL ESTIMATES ESTIMATED FROM RAW DATA [task] task = fit data = equilibria [mechanism] R72 + Neo R72.Neo : K dissoc [constants] K = 0.3 ?? [concentrations] R72 = 0.1 ; fixed! [responses] R72 = 10 ? R72.Neo = 8.5 ?... File.. Try

BKEB Lec 4: Equilibrium Binding25 Experiment #2: RRE / Neomycin – results USING INITIAL ESTIMATES FROM PREVIOUS SLIDE K d, µM  0.56 parameterbest-fit value formal error, ± 0.07 confidence interval (95%) DynaFit output:

BKEB Lec 4: Equilibrium Binding26 Experiment #1 & #2: Summary ONLY BINARY INTERACTIONS STUDIED SO FAR Suc-TRQARRNRRRRWRERQRAAAAK Rev model peptide: * fluorescent probe on U72 K d = 290 nM K d = 6 nM

BKEB Lec 4: Equilibrium Binding27 The main question remains unanswered Could Neomycin prevent the Rev peptide from binding to the RNA? in other words: Is the binding of Rev and Neomycin simultaneous or exclusive? non-competitive competitive And how do we translate these ideas into stoichiometric notation? DynaFit

BKEB Lec 4: Equilibrium Binding28 Simultaneous vs. exclusive: stoichiometry IT DEPENDS ON HOW MANY DIFFERENT COMPLEXES ARE FORMED EXCLUSIVE: Neo + RRE + Rev NeoRRE + RRERev SIMULTANEOUS: Neo + RRE + Rev NeoRRE + RRERev + NeoRRERev not necessarily different binding sites always at different binding sites

BKEB Lec 4: Equilibrium Binding29 Simultaneous vs. exclusive: DynaFit notation HOW MANY DIFFERENT COMPLEXES IS NOT THE ONLY QUESTION [mechanism] ; exclusive RRE + Rev RRE.Rev : Kr dissoc Neo + RRE Neo.RRE : Kn dissoc [mechanism] ; simultaneous RRE + Rev RRE.Rev : Kr dissoc Neo + RRE Neo.RRE : Kn dissoc ??? + ??? Neo.RRE.Rev : ?? dissoc what goes here?

BKEB Lec 4: Equilibrium Binding30 Two new concepts to consider BEFORE WE CAN FINISH OUR DYNAFIT SCRIPT 1.“thermodynamic box” 2.independent vs. interacting sites

BKEB Lec 4: Equilibrium Binding31 From stoichiometry to molecular mechanism ONLY BIMOLECULAR INTERACTIONS ARE REALISTIC: THREE MOLECULES NEVER COLLIDE ! A + B + CAB + BC + ABC overall stoichiometry: possible molecular mechanisms: BBABAB +A+A+C+C ABCABC BBBCBC +C+C sequential I BBABAB +A+A +A+A ABCABCBBBCBC +C+C sequential II BBABAB +A+A +A+A ABCABCBBBCBC +C+C random +C+C ABCABC

BKEB Lec 4: Equilibrium Binding32 Thermodynamic box: A very general idea NO MATTER WHICH PATH WE TAKE, THE FREE-ENERGY CHANGE MUST BE THE SAME BB ABAB ABCABC BCBC KAKA KCAKCA KCKC KACKAC all “K”s are dissociation constants K CA  K A = K AC  K C dissociation from ABC: first C then A dissociation from ABC: first A then C Only three of four equilibrium constants can have an arbitrary value. Any one of the K’s is a priori defined in terms of the remaining three. It does not matter which K we select to be dependent on the remaining three.

BKEB Lec 4: Equilibrium Binding33 Thermodynamic box: DynaFit notation THERE ARE MULTIPLE EQUIVALENT WAYS TO SPECIFY THE “RANDOM” MECHANISM IN DYNAFIT BB ABAB ABCABC BCBC KAKA KCAKCA KCKC KACKAC all “K”s are dissociation constants [mechanism] A + B AB : Kc diss B + C BC : Kc diss AB + C ABC : Kca diss [mechanism] A + B AB : Ka diss B + C BC : Kc diss A + BC ABC : Kac diss or, equivalently: There must be only three steps (any three) in the DynaFit notation! for example: How many other ways exist to specify this mechanism in DynaFit ?

BKEB Lec 4: Equilibrium Binding34 Independent / interacting sites WHETHER OR NOT PAIRS OF EQUILIBRIUM CONSTANTS IN THE “BOX” ARE THE SAME BB ABAB ABCABC BCBC KAKA KCAKCA KCKC KACKAC all “K”s are dissociation constants independent sites: K CA = K C K AC = K A interacting sites: K CA  K C K AC  K A

BKEB Lec 4: Equilibrium Binding35 Independent sites: DynaFit notation THERE ARE MULTIPLE EQUIVALENT WAYS TO SPECIFY THIS, TOO BB ABAB ABCABC BCBC KAKA KCKC KCKC KAKA all “K”s are dissociation constants [mechanism] A + B AB : KA diss B + C BC : Kc diss AB + C ABC : Kc diss [mechanism] A + B AB : Ka diss B + C BC : Kc diss A + BC ABC : Ka diss or, equivalently: for example: Only two distinct dissociation constants.

BKEB Lec 4: Equilibrium Binding36 Simultaneous vs. exclusive: DynaFit notation FINALLY WE KNOW ENOUGH THEORY TO FINISH THE DYNAFIT SCRIPT [mechanism] ; exclusive RRE + Rev RRE.Rev : Kr dissoc Neo + RRE Neo.RRE : Kn dissoc [mechanism] ; simultaneous, non-interacting RRE + Rev RRE.Rev : Kr dissoc Neo + RRE Neo.RRE : Kn dissoc Neo.RRE + Rev Neo.RRE.Rev : Kr dissoc [mechanism] ; simultaneous, interacting RRE + Rev RRE.Rev : Kr dissoc Neo + RRE Neo.RRE : Kn dissoc Neo.RRE + Rev Neo.RRE.Rev : Krn dissoc

BKEB Lec 4: Equilibrium Binding37 Automatic model selection in DynaFit [task] task = fit data = equilibria model = exclusive ?... [task] task = fit data = equilibria model = interacting ?... [task] task = fit data = equilibria model = non-interacting ?...

BKEB Lec 4: Equilibrium Binding38 Model selection: round 1 – fixed [RNA] NEITHER MODEL FITS VERY WELL AT ALL! exclusivenon-interactinginteracting experiment #3 labeled [RNA]: Neomycin B: Rev peptide: 100 nM, constant 990 nM, constant 0 – 655 nM, varied [RNA] is under suspicion All equilibrium constants were fixed at values determined in binary binding studies.

BKEB Lec 4: Equilibrium Binding39 Model selection: round 2 – optimized [RNA] GOODNESS-OF-FIT IS MUCH IMPROVED exclusivenon-interactinginteracting experiment #3 labeled [RNA]: Neomycin B: Rev peptide: 178 nM, optimized in the fit 990 nM, constant 0 – 655 nM, varied SSQ r = 3.094SSQ r = 1.002SSQ r = w AIC = 0.000w AIC = 0.948w AIC = non-interacting actual [RNA] 78% higher than nominal?

BKEB Lec 4: Equilibrium Binding40 Mechanism for HIV-1 RRE / Neomycin / Rev RRE RevRRE RevRRENeo RRENeo K d = 5 nM290 nM 5 nM290 nM NON-EXCLUSIVE BINDING TO TWO DISTINCT, NON-INTERACTING SITES

BKEB Lec 4: Equilibrium Binding41 Mechanism for HIV-1 RRE / Neomycin / Rev STRUCTURAL IMPLICATIONS OF THE BINDING DATA: SEPARATE BINDING SITES Suc-TRQARRNRRRRWRERQRAAAAK Rev model peptide: * fluorescent probe on U72 “Neo” site “Rev” site K d = 5 nM K d = 290 nM

BKEB Lec 4: Equilibrium Binding42 Summary and conclusions 1.Equilibrium binding data are easily handled by numerical models. Arbitrary conditions (no “excess of A over B”); arbitrarily complex mechanisms. 2.Certain restrictions exist on representing reaction mechanisms. The “thermodynamic box” rule must always be obeyed. 3.Exclusive vs. non-exclusive binding is expressed simply as a different number of complexes present in the overall mechanism. 4.Interacting vs. non-interacting sites are expressed simply by assigning identical vs. unique values to equilibrium constants. 5.Incorrectly specified concentrations have a large impact on best-fit values of equilibrium constants and on model selection. BUT THERE IS SOME RELIEF: when the binding is “tight”, actual concentrations can be inferred from the data; when the binding is “loose”, systematic concentration errors do not matter (much). 6.DynaFit is not a “silver bullet”: You must still use your brain a lot.